Argent Biopharma Limited has released a press release.
Trading Halt
Filed with ASX ·
On 6ix: 6ix.com/news/trading-halt-1361
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- ASX Listing Update
- Placing to Raise A$200,000
- Preliminary Final Report
- Voluntary Delisting from ASX
- Placing to Raise US$2,000,000
Later from Argent Biopharma
- Placing to Raise US$4,500,000
- Corporate Update - Board Change
- Half Year Accounts
- Strategic Manufacturing Partnership with ECCPharm Limited
- Exclusive Agreement for Malta Manufacturing Facility
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma